CytoMed Therapeutics (GDTC) Q1 2025 Earnings
GDTC·Reported March 31, 2025·Before market open
CytoMed Therapeutics reported Q1 2025 revenue of $74.3K. Diluted EPS came in at $-0.05.
Revenue
$74.3K
Diluted EPS
$-0.05
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2025 Earnings FAQ
Common questions about CytoMed Therapeutics's Q1 2025 earnings report.
CytoMed Therapeutics (GDTC) reported Q1 2025 earnings on March 31, 2025 before market open.
CytoMed Therapeutics reported revenue of $74.3K and diluted EPS of $-0.05 for Q1 2025.